These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 8806576

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
    Yoshimoto T, Nagase H, Nakano H, Matsuzawa A, Nariuchi H.
    Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
    [Abstract] [Full Text] [Related]

  • 3. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ, Novick MB, Palmer LD, Knepper JE.
    J Immunol; 1993 Feb 15; 150(4):1422-8. PubMed ID: 8094408
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I, Erny K, Acha-Orbea H, Diggelmann H.
    Eur J Immunol; 1996 May 15; 26(5):1000-6. PubMed ID: 8647159
    [Abstract] [Full Text] [Related]

  • 8. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
    Ando Y, Wajjwalku W, Niimi N, Hiromatsu K, Morishima T, Yoshikai Y.
    J Immunol; 1995 Jun 15; 154(12):6219-26. PubMed ID: 7759859
    [Abstract] [Full Text] [Related]

  • 9. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity.
    Papiernik M, do Carmo Leite-de-MoraesM, Pontoux C, Joret AM, Rocha B, Penit C, Dy M.
    J Immunol; 1997 May 15; 158(10):4642-53. PubMed ID: 9144476
    [Abstract] [Full Text] [Related]

  • 10. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY, Jouvin-Marche E, Marche PN, MacDonald HR, Acha-Orbea H.
    Eur J Immunol; 1995 Mar 15; 25(3):857-62. PubMed ID: 7705418
    [Abstract] [Full Text] [Related]

  • 11. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
    Penninger JM, Wallace VA, Timms E, Mak TW.
    Eur J Immunol; 1994 May 15; 24(5):1102-8. PubMed ID: 8181521
    [Abstract] [Full Text] [Related]

  • 12. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
    Modlin CS, Todd GT, Cohen TD, Fairchild RL.
    Cell Immunol; 1995 Sep 15; 164(2):217-26. PubMed ID: 7656330
    [Abstract] [Full Text] [Related]

  • 13. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells.
    Luther SA, Maillard I, Luthi F, Scarpellino L, Diggelmann H, Acha-Orbea H.
    J Immunol; 1997 Sep 15; 159(6):2807-14. PubMed ID: 9300703
    [Abstract] [Full Text] [Related]

  • 14. CD4 expression is important but not essential for infection with exogenous mouse mammary tumor virus.
    Ando Y, Wajjwalku W, Kishihara K, Arai T, Niimi N, Hiromatsu K, Morishima T, Yoshikai Y.
    Immunobiology; 1996 Aug 15; 195(3):376-84. PubMed ID: 8877410
    [Abstract] [Full Text] [Related]

  • 15. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F, Wirth S, Maillard I, Valsesia S, Acha-Orbea H, Diggelmann H.
    J Virol; 2001 Aug 15; 75(16):7453-61. PubMed ID: 11462017
    [Abstract] [Full Text] [Related]

  • 16. Deletion of CD4+ T cells and thymocytes by apoptosis in mouse mammary tumor virus (C4)-infected V beta 2 transgenic mice.
    Wang H, Gill RF, Lichlyter D, Iglesias A, Bluethmann H, Wei WZ.
    Eur J Immunol; 1994 Dec 15; 24(12):2950-6. PubMed ID: 7805721
    [Abstract] [Full Text] [Related]

  • 17. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
    Palmer LD, Saha B, Hodes RJ, Abe R.
    J Immunol; 1996 Mar 15; 156(6):2112-8. PubMed ID: 8690899
    [Abstract] [Full Text] [Related]

  • 18. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
    Golovkina TV, Dudley JP, Ross SR.
    J Immunol; 1998 Sep 01; 161(5):2375-82. PubMed ID: 9725233
    [Abstract] [Full Text] [Related]

  • 19. Alleviation of renal disease and lymphadenopathy in MRL-Fasp(lrcg)/Fas(lprcg) (MR-lpr(cg)) mice neonatally infected with mouse mammary tumor virus encoding superantigen strongly reactive with TCR Vbeta8.2 element.
    Matsuzawa A, Yasuda T, Zhang Y, Nagase H, Yoshimoto T, Kimura M, Tsubura A.
    Viral Immunol; 2000 Sep 01; 13(3):297-311. PubMed ID: 11016595
    [Abstract] [Full Text] [Related]

  • 20. In vivo T cell response to viral superantigen. Selective migration rather than proliferation.
    Le Bon A, Lucas B, Vasseur F, Penit C, Papiernik M.
    J Immunol; 1996 Jun 15; 156(12):4602-8. PubMed ID: 8648102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.